Standout Papers

Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin 2023 2026 202484
  1. Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin (2023)
    Julio Rosenstock, Stephen C. Bain et al. New England Journal of Medicine

Immediate Impact

8 standout
Sub-graph 1 of 4

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
2024 Standout
2 intermediate papers

Works of Amoolya Gowda being referenced

Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5)
2023
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial
2021

Author Peers

Author Last Decade Papers Cites
Amoolya Gowda 275 94 106 12 289
Daniel A. Nadeau 167 57 91 12 300
Fredrik Thorén 261 58 194 16 281
Eileen Tichy 260 134 189 13 304
Deborah E Seigler 263 79 88 9 324
Xiaojun Luan 201 74 85 11 336
D Koev 184 53 55 19 308
I Nosari 167 58 87 14 221
Diane M. Karl 190 42 63 12 304
Alexander Seibold 253 143 124 12 286
Annelie Fischer 173 74 84 13 290

All Works

Loading papers...

Rankless by CCL
2026